Prevention & Chronic Conditions

Broadcast

Clone of The New Era in AF Screening at Home

Jerry Luck, , , et al

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

Personalised Approaches to Improving the Effect of Anti-platelet Agents: Where Do We Stand?

Citation:

European Cardiology Review 2019;14(3):179–80

Protocol of a Randomised, Single Blind, Placebo-controlled RESCAP Intervention Study to Determine the Safety of RESCAP in Diabetes: RAPID Protocol – Rationale and Design

Citation:

European Cardiology Review 2020;15:e41.

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease

Published:

26 February 2020

Citation:

European Cardiology Review 2020;15:e04.

Hypotensive Action of Melatonin in Patients with Arterial Hypertension

Citation:

European Cardiology Review 2020;15:e43.